Notable Labs, Ltd. (NTBL )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol NTBL
- Company Notable Labs, Ltd.
- Price $0.27
- Changes Percentage -31.09
- Change -0.1213
- Day Low $0.25
- Day High $0.3
- Year High $5.27
- Year Low $0.25
- Market Cap $2,596,474
- Price Avg 50 EMA (D) $0.49
- Price Avg 200 EMA (D) $0.96
- Exchange NASDAQ
- Volume 1,902,667
- Average Volume 77,678
- Open $0.3
- Previous Close $0.39
- EPS -1.09
- PE -0.25
- Earnings Announcement 2024-11-12 10:59:00
- Shares Outstanding $9,659,500
Company brief: NOTABLE LABS, LTD. (NTBL )
- Healthcare
- Biotechnology
- Dr. Thomas A. Bock M.B.A., M.D.
- https://www.notablelabs.com
- US
- N/A
- 10-01-2014
- IL0012002452
Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.